Skip to content

Skin condition improvement evaluation and safty confirmation by application of moisturizing gel "HCDMJ"

Skin condition improvement evaluation and safty confirmation by application of moisturizing gel "HCDMJ" - Skin condition improvement evaluation and safty confirmation by application of moisturizing gel "HCDMJ"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056329
Enrollment
20
Registered
2024-12-13
Start date
2025-01-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

To apply moisturizing gel &quot
HCDMJ&quot
several times a day to both arms

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged 20 years to 59 years old??at the time of informed consent 2) Those who can agree not to use body care products other than the test product (including external moisturizing agents such as heparin-like substances) during the test period 3) Those with mild to moderate atopic dermatitis symptoms such as dryness, flakiness, flaking, and peeling on the arms (inner elbows, inner forearms, etc.)

Exclusion criteria

Exclusion criteria: 1) Those who are applying or likely to apply drugs to the test site during the test period 2) Those who have taken steroids or immunosuppressive drugs within one month before the start of the study 3) Those with severe atopic dermatitis or psoriasis 4) Those who may allergic to the test product components 5) Those who regularly use health foods that claim moisturizing effects (ceramides, hyaluronic acid, etc.) 6) Those participating in other clinical trials during the study period

Design outcomes

Primary

MeasureTime frame
skin moisture content, transepidermal water loss, sebum amount, skin texture, skin viscoelasticity, questionnaire, doctor's fidings at 0-2-4 weeks

Countries

Japan

Contacts

Public ContactMiwa Kaneko

SOUKEN Co., Ltd Management Division

jimukyoku@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026